CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
Our COVID-19 evidence portal contains the latest COVID-19 information from CADTH and other respected organizations. Content is updated daily to reflect the rapidly changing and growing state of the international scientific evidence related to this disease.
The following is a summary of the most recent information posted to our COVID-19 portal.
- Register to attend this webinar to hear about the findings of an evidence review on internet-delivered cognitive behavioural therapy (iCBT) for post-traumatic stress disorder (PTSD).
- Dr. Rima Styra, Associate Professor of Psychiatry at the University of Toronto will join us to offer a clinician’s perspective on the impact of this pandemic on people’s mental health and the role that iCBT can have in the treatment of PTSD.
- Other featured speakers include Louise Bradley from the Mental Health Commission of Canada and CADTH’s Eftyhia Helis.
- This issue of Health Technology Update features brief summaries of information on a range of technologies that aim to support the prevention, identification, and management of COVID-19 — from smartphone apps for contact tracing to self-collected sampling for diagnostic testing.
- These technologies were identified through the CADTH Horizon Scanning Service as topics of potential interest to health care decision-makers in Canada.
- Convalescent plasma (CP) therapy is an intervention where plasma is collected from patients who recovered from COVID-19 in the hope that the disease-specific antibodies could help the recipient recover from COVID-19.
- Evidence on the effectiveness of CP therapy for the treatment of COVID-19 is still in the early stages.
- This report summarizes the current evidence and it will be updated monthly as a living review.
- Since the Addendum to the April 20, 2020 Brief Overview was published on May 29, 2020, The Lancet retracted an article that had significant impact on the conduct of clinical trials of hydroxychloroquine in the treatment of COVID-19.
- A review of the latest development and publication is ongoing and a report will be posted shortly.
CADTH Literature Searching Tools
CADTH is pleased to showcase additional COVID-19 resources from our partner organizations, as well as from the Canadian federal, provincial, and territorial governments’ health jurisdictions:
Can't Find What You Need? Let Us Know
Canadian ministries and departments of health, publicly funded organizations responsible for health service delivery, and clinical society stakeholders are encouraged to submit a request or contact their CADTH Liaison Officer. We’re here to help.
The CADTH Weekly COVID-19 Update is intended to keep you informed about the latest information posted on the CADTH COVID-19 portal. You’re receiving this update because you’ve subscribed to our CADTH e-alert system.